Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Heart Test Laboratories, Inc. - Common Stock (NQ: HSCS ) 3.560 +0.080 (+2.30%) Streaming Delayed Price Updated: 9:44 AM EDT, Aug 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Heart Test Laboratories, Inc. - Common Stock < Previous 1 2 Next > HeartSciences Announces Further Expansion of Artificial Intelligence (AI) Patent Portfolio August 17, 2023 European Patent Allowed for Quantification by an ECG of Key Heart Measures using AI From Heart Test Laboratories, Inc. Via GlobeNewswire MyoVista wavECG goes into clinical use at the Naya Imaging Center in Denmark July 27, 2023 From Heart Test Laboratories, Inc. Via GlobeNewswire HeartSciences Provides Business Update and Reports Fiscal 2023 Financial Results July 19, 2023 From Heart Test Laboratories, Inc. Via GlobeNewswire HeartSciences Named as a Top 10 Healthcare Artificial Intelligence Solutions Provider 2023 by Healthcare Tech Outlook Magazine May 17, 2023 From Heart Test Laboratories, Inc. Via GlobeNewswire HeartSciences Announces Completion of Patient Enrollment for FDA Pivotal Study of MyoVista wavECG May 09, 2023 From Heart Test Laboratories, Inc. Via GlobeNewswire HeartSciences to Participate at the Inaugural EF Hutton Global Conference May 08, 2023 From Heart Test Laboratories, Inc. Via GlobeNewswire HeartSciences to Participate in The Benchmark Company’s Virtual Individual Investor Healthcare Conference May 02, 2023 From Heart Test Laboratories, Inc. Via GlobeNewswire HeartSciences to Present at the Planet MicroCap Showcase: VEGAS 2023 April 17, 2023 From Heart Test Laboratories, Inc. Via GlobeNewswire HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2023 Financial Results March 16, 2023 From Heart Test Laboratories, Inc. Via GlobeNewswire HeartSciences CEO Invited as Featured Guest on The Big Biz Show, February 7 at 11:45 a.m. Pacific Time February 07, 2023 From Heart Test Laboratories, Inc. Via GlobeNewswire HeartSciences Granted Key Israeli International Patent for its MyoVista® Wavelet Technology Utilizing Artificial Intelligence (AI) for Early Detection of Heart Disease February 06, 2023 Israeli patent covers a country known as a hotbed for medical device innovation From Heart Test Laboratories, Inc. Via GlobeNewswire HeartSciences Announces Further Internationalization of its Patent Portfolio February 03, 2023 Granted Korean Patent for its MyoVista® Wavelet Technology From Heart Test Laboratories, Inc. Via GlobeNewswire Correction: HeartSciences CEO to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on January 25th January 23, 2023 From Heart Test Laboratories, Inc. Via GlobeNewswire HeartSciences CEO to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on January 25th January 20, 2023 From Heart Test Laboratories, Inc. Via GlobeNewswire HeartSciences Appoints David R. Wells to its Board of Directors, an Experienced Capital Markets and Finance Executive January 04, 2023 From Heart Test Laboratories, Inc. Via GlobeNewswire HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2023 Financial Results December 16, 2022 Patient Enrollment Close to Completion and Continue to Target FDA De Novo Resubmission Around Current Fiscal Year End From Heart Test Laboratories, Inc. Via GlobeNewswire HeartSciences and Rutgers University Announce Multi-Year Collaboration to Develop AI-based ECG Algorithms December 01, 2022 From Heart Test Laboratories, Inc. Via GlobeNewswire HeartSciences to Present at the 2022 RHK Disruptive Growth Conference on December 5, 2022 November 28, 2022 From Heart Test Laboratories, Inc. Via GlobeNewswire HeartSciences to Participate at the Benchmark Discovery One-on-One Investor Conference on December 1, 2022 November 21, 2022 From Heart Test Laboratories, Inc. Via GlobeNewswire HeartSciences’ MyoVista® Technology Used to Develop AI-ECG Algorithm to Identify Patients at High-Risk of Major Adverse Cardiovascular Events November 10, 2022 Independent study demonstrates novel AI-ECG algorithm could provide a cost-effective strategy for improving cardiac risk stratification From Heart Test Laboratories, Inc. Via GlobeNewswire HeartSciences Granted European Patent for Proprietary Electrode and Cable Connections for Use with its AI-Based MyoVista® ECG October 25, 2022 Patent builds on previously granted U.S. patent as well as strengthens and diversifies the IP portfolio and further protects future revenues From Heart Test Laboratories, Inc. Via GlobeNewswire HeartSciences Named as a Top 10 MedTech Startup 2022 by MedTech Outlook Magazine October 20, 2022 From Heart Test Laboratories, Inc. Via GlobeNewswire HeartSciences to Present at MicroCap Rodeo's Windy City Roundup Conference on October 12th October 06, 2022 Via ACCESSWIRE < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
